Whether so-called micro-hospitals can succeed financially might depend on whether they can meet Medicare’s definition of a hospital: a medical facility that dedicates the bulk of its services to inpatient care.
The Catalyst Award recognizes companies that excel in addressing recruitment, development and advancement of women. Today, nearly half of Lilly's senior leadership is female, up from 20 percent four years ago.
Connecticut-based Loxo Oncology, which was founded in 2013 and went public a year later, has a cancer drug in development that recently received U.S. Food and Drug Administration "breakthrough therapy" status.
Bristol-Myers and Celgene combined will have nine products with more than $1 billion in annual sales and significant potential for growth in the core disease areas of oncology, immunology and cardiovascular disease.
Justin Markel and Quinton Lasko are obsessed with feet and legs, technology and helping people improve their mobility. The combination led the duo to an invention designed to help athletes, although it has applications far beyond sports.
The West Lafayette biotech firm's stock traded as low as $1.41 last fall, following multiple setbacks and restructurings. But the stock had soared to $24 Thursday morning after news that it would be acquired by Novartis.